Organ preservation for advanced laryngeal carcinoma

Robert L. Foote, R. Tyler Foote, Paul D. Brown, Yolanda Isabel Garces, Scott Heitaka Okuno, Scott E. Strome

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background. Inclusion of patients with mobile vocal cords on larynx preservation trials may lead to overstatement of larynx preservation (LPR) and survival (OS) rates. Methods. This is a retrospective review of patients at our institution who would have been eligible for the Department of Veterans Affairs Laryngeal Cancer Study Group (VA) and Radiation Therapy Oncology Group/Head and Neck Intergroup (RTOG 91-11) clinical trials. No laryngeal conservation procedure could be performed in patients with mobile vocal cords. Results. One hundred one patients at our institution would have been eligible for the VA trial. The 2-year OS was 76% for total laryngectomy and 90% for radiotherapy patients (p = .28) compared with 68% reported for the VA trial. Seventy-three patients at our institution would have been eligible for the RTOG 91-11 trial. The 5-year OS was 52% for total laryngectomy and 63% for radiotherapy patients (p = .18) compared with 55% reported for the RTOG 91-11 trial. Radiotherapy patients had an LPR of 80% (VA trial) and 86% (RTOG 91-11 trial). Conclusion. It is unlikely that inclusion of patients with mobile vocal cords had a significant impact on OS or LPR for the VA and RTOG 91-11 larynx preservation trials.

Original languageEnglish (US)
Pages (from-to)689-696
Number of pages8
JournalHead and Neck
Volume28
Issue number8
DOIs
StatePublished - Aug 2006

Fingerprint

Organ Preservation
Carcinoma
Larynx
Vocal Cords
Radiotherapy
Laryngectomy
Radiation Oncology
Laryngeal Neoplasms
Veterans
Group Psychotherapy
Neck
Survival Rate
Head
Clinical Trials

Keywords

  • Chemoradiotherapy
  • Laryngeal carcinoma
  • Organ preservation
  • Total laryngectomy

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Foote, R. L., Foote, R. T., Brown, P. D., Garces, Y. I., Okuno, S. H., & Strome, S. E. (2006). Organ preservation for advanced laryngeal carcinoma. Head and Neck, 28(8), 689-696. https://doi.org/10.1002/hed.20387

Organ preservation for advanced laryngeal carcinoma. / Foote, Robert L.; Foote, R. Tyler; Brown, Paul D.; Garces, Yolanda Isabel; Okuno, Scott Heitaka; Strome, Scott E.

In: Head and Neck, Vol. 28, No. 8, 08.2006, p. 689-696.

Research output: Contribution to journalArticle

Foote, RL, Foote, RT, Brown, PD, Garces, YI, Okuno, SH & Strome, SE 2006, 'Organ preservation for advanced laryngeal carcinoma', Head and Neck, vol. 28, no. 8, pp. 689-696. https://doi.org/10.1002/hed.20387
Foote, Robert L. ; Foote, R. Tyler ; Brown, Paul D. ; Garces, Yolanda Isabel ; Okuno, Scott Heitaka ; Strome, Scott E. / Organ preservation for advanced laryngeal carcinoma. In: Head and Neck. 2006 ; Vol. 28, No. 8. pp. 689-696.
@article{20518b1570c045148553221e7cddbee7,
title = "Organ preservation for advanced laryngeal carcinoma",
abstract = "Background. Inclusion of patients with mobile vocal cords on larynx preservation trials may lead to overstatement of larynx preservation (LPR) and survival (OS) rates. Methods. This is a retrospective review of patients at our institution who would have been eligible for the Department of Veterans Affairs Laryngeal Cancer Study Group (VA) and Radiation Therapy Oncology Group/Head and Neck Intergroup (RTOG 91-11) clinical trials. No laryngeal conservation procedure could be performed in patients with mobile vocal cords. Results. One hundred one patients at our institution would have been eligible for the VA trial. The 2-year OS was 76{\%} for total laryngectomy and 90{\%} for radiotherapy patients (p = .28) compared with 68{\%} reported for the VA trial. Seventy-three patients at our institution would have been eligible for the RTOG 91-11 trial. The 5-year OS was 52{\%} for total laryngectomy and 63{\%} for radiotherapy patients (p = .18) compared with 55{\%} reported for the RTOG 91-11 trial. Radiotherapy patients had an LPR of 80{\%} (VA trial) and 86{\%} (RTOG 91-11 trial). Conclusion. It is unlikely that inclusion of patients with mobile vocal cords had a significant impact on OS or LPR for the VA and RTOG 91-11 larynx preservation trials.",
keywords = "Chemoradiotherapy, Laryngeal carcinoma, Organ preservation, Total laryngectomy",
author = "Foote, {Robert L.} and Foote, {R. Tyler} and Brown, {Paul D.} and Garces, {Yolanda Isabel} and Okuno, {Scott Heitaka} and Strome, {Scott E.}",
year = "2006",
month = "8",
doi = "10.1002/hed.20387",
language = "English (US)",
volume = "28",
pages = "689--696",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Organ preservation for advanced laryngeal carcinoma

AU - Foote, Robert L.

AU - Foote, R. Tyler

AU - Brown, Paul D.

AU - Garces, Yolanda Isabel

AU - Okuno, Scott Heitaka

AU - Strome, Scott E.

PY - 2006/8

Y1 - 2006/8

N2 - Background. Inclusion of patients with mobile vocal cords on larynx preservation trials may lead to overstatement of larynx preservation (LPR) and survival (OS) rates. Methods. This is a retrospective review of patients at our institution who would have been eligible for the Department of Veterans Affairs Laryngeal Cancer Study Group (VA) and Radiation Therapy Oncology Group/Head and Neck Intergroup (RTOG 91-11) clinical trials. No laryngeal conservation procedure could be performed in patients with mobile vocal cords. Results. One hundred one patients at our institution would have been eligible for the VA trial. The 2-year OS was 76% for total laryngectomy and 90% for radiotherapy patients (p = .28) compared with 68% reported for the VA trial. Seventy-three patients at our institution would have been eligible for the RTOG 91-11 trial. The 5-year OS was 52% for total laryngectomy and 63% for radiotherapy patients (p = .18) compared with 55% reported for the RTOG 91-11 trial. Radiotherapy patients had an LPR of 80% (VA trial) and 86% (RTOG 91-11 trial). Conclusion. It is unlikely that inclusion of patients with mobile vocal cords had a significant impact on OS or LPR for the VA and RTOG 91-11 larynx preservation trials.

AB - Background. Inclusion of patients with mobile vocal cords on larynx preservation trials may lead to overstatement of larynx preservation (LPR) and survival (OS) rates. Methods. This is a retrospective review of patients at our institution who would have been eligible for the Department of Veterans Affairs Laryngeal Cancer Study Group (VA) and Radiation Therapy Oncology Group/Head and Neck Intergroup (RTOG 91-11) clinical trials. No laryngeal conservation procedure could be performed in patients with mobile vocal cords. Results. One hundred one patients at our institution would have been eligible for the VA trial. The 2-year OS was 76% for total laryngectomy and 90% for radiotherapy patients (p = .28) compared with 68% reported for the VA trial. Seventy-three patients at our institution would have been eligible for the RTOG 91-11 trial. The 5-year OS was 52% for total laryngectomy and 63% for radiotherapy patients (p = .18) compared with 55% reported for the RTOG 91-11 trial. Radiotherapy patients had an LPR of 80% (VA trial) and 86% (RTOG 91-11 trial). Conclusion. It is unlikely that inclusion of patients with mobile vocal cords had a significant impact on OS or LPR for the VA and RTOG 91-11 larynx preservation trials.

KW - Chemoradiotherapy

KW - Laryngeal carcinoma

KW - Organ preservation

KW - Total laryngectomy

UR - http://www.scopus.com/inward/record.url?scp=33746335378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746335378&partnerID=8YFLogxK

U2 - 10.1002/hed.20387

DO - 10.1002/hed.20387

M3 - Article

C2 - 16619278

AN - SCOPUS:33746335378

VL - 28

SP - 689

EP - 696

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 8

ER -